Body size and prostate cancer: A population-based case-control study in China

被引:0
|
作者
Hsing, AW
Deng, J
Sesterhenn, IA
Mostofi, FK
Stanczyk, FZ
Benichou, J
Xie, T
Gao, YT
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA
[2] Inst Canc Res, Shanghai, Peoples R China
[3] Univ So Calif, Los Angeles, CA 90033 USA
[4] Univ Rouen, F-76031 Rouen, France
[5] Armed Forces Inst Pathol, Washington, DC 20306 USA
[6] Shanghai First Municipal Hosp, Dept Urol, Shanghai 200032, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We conducted a population-based case-control study in China to investigate whether body size plays a role in prostate cancer etiology and whether it can explain the rapid increase in prostate cancer incidence rates in China. A total of 238 cases newly diagnosed with primary prostate cancer in Shanghai, China, during 1993-1995 were included in the study. Four hundred and seventy-one healthy control subjects were randomly selected from among residents of Shanghai and frequency-matched to cases on the basis of age. In-person interviews were conducted to elicit information on height, weight history, and other lifestyle factors, Waist and hip circumferences were measured at interview. Odds ratios (ORs) were used to measure the association between prostate cancer and anthropometric variables including height, weight, body mass index (BMI), waist, hip, end right upper arm circumferences, and waist-to-hip ratio (WHR; an indicator of abdominal adiposity), High levels of WHR were related to an excess risk, with men in the highest quartile WKR > 0.92) having an almost 3-fold risk (OR, 2.71; 95% CI = 1.66-4.41; P-trend = 0.0001) compared with men in the lowest quartile (WHR < 0,86), In contrast, men in the highest quartile of hip circumference (>97.4 cm) had a reduced risk (OR, 0.46; 95% CI = 0.29-0.74; P-trend = 0.0002) relative to men in the lowest quartile (<86 cm), No association was found for height, usual adult weight, or preadult and usual adult BMI, Our results suggest that even in a very lean population (average BMI = 21,9), abdominal adiposity may be associated with an increased risk of clinical prostate cancer, pointing to a role of hormones in prostate cancer etiology, Additional research is needed to confirm these findings in prospective studies, especially in Western populations where abdominal obesity is much more common, and to clarify the underlying hormonal mechanisms involved.
引用
收藏
页码:1335 / 1341
页数:7
相关论文
共 50 条
  • [31] Lung Cancer and Occupation in a Population-based Case-Control Study
    Consonni, Dario
    De Matteis, Sara
    Lubin, Jay H.
    Wacholder, Sholom
    Tucker, Margaret
    Pesatori, Angela Cecilia
    Caporaso, Neil E.
    Bertazzi, Pier Alberto
    Landi, Maria Teresa
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (03) : 323 - 333
  • [32] Myasthenia and risk of cancer: a population-based case-control study
    Pedersen, E. G.
    Pottegard, A.
    Hallas, J.
    Friis, S.
    Hansen, K.
    Jensen, P. E. H.
    Gaist, D.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (05) : 773 - 778
  • [33] Fathering of Dizygotic Twins and Risk of Prostate Cancer: Nationwide, Population-Based Case-Control Study
    Wiren, Sara
    Drevin, Linda
    Akre, Olof
    Robinson, David
    Stattin, Par
    [J]. PLOS ONE, 2014, 9 (10):
  • [34] Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
    Bratt, O
    Kristoffersson, U
    Lundgren, R
    Olsson, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (02) : 272 - 277
  • [35] Ambient air pollution and prostate cancer risk in a population-based Canadian case-control study
    Youogo, Leslie Michele-Ange Kouam
    Parent, Marie-Elise
    Hystad, Perry
    Villeneuve, Paul J.
    [J]. ENVIRONMENTAL EPIDEMIOLOGY, 2022, 6 (04) : E219
  • [36] The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study
    Dawe, David E.
    Ye, Xibiao
    Czaykowski, Piotr
    Jassal, Davinder
    Singh, Harminder
    Skarsgard, David
    Aprikian, Armen
    Mahmud, Salaheddin M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (01) : 190 - 198
  • [37] Cholesterol-lowering drugs and prostate cancer risk: A population-based case-control study
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Lahtela, Jorma
    Auvinen, Anssi
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) : 2226 - 2232
  • [38] Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada
    Blanc-Lapierre, Audrey
    Spence, Andrea
    Karakiewicz, Pierre I.
    Aprikian, Armen
    Saad, Fred
    Parent, Marie-Elise
    [J]. BMC PUBLIC HEALTH, 2015, 15
  • [39] Energy, nutrient intake and prostate cancer risk: A population-based case-control study in Sweden
    Andersson, SO
    Wolk, A
    Bergstrom, R
    Giovannucci, E
    Lindgren, C
    Baron, J
    Adami, HO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1996, 68 (06) : 716 - 722
  • [40] Screening digital rectal examination and prostate cancer mortality: A population-based case-control study
    Jacobsen, SJ
    Bergstralh, EJ
    Katusic, SK
    Guess, HA
    Darby, CH
    Silverstein, MD
    Oesterling, JE
    Lieber, MM
    [J]. UROLOGY, 1998, 52 (02) : 173 - 179